Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial

Journal:
The Lancet
Published:
DOI:
10.1016/s0140-6736(25)02360-8
Affiliations:
31
Authors:
197
Go to article
Institutions Authors Share
AbbVie, United States of America (USA)
5.000000
 0.17
Manchester Cancer Research Centre (MCRC), United Kingdom (UK)
1.000000
 0.03
North Shore Hospital, New Zealand
1.000000
 0.03
Groupe de Recherche sur les formes Injectables et les Technologies Associées (GRITA), France
1.000000
 0.03
University of Debrecen, Hungary
1.000000
 0.03
University Hospital Královské Vinohrady, Czech Republic
1.000000
 0.03
Genmab A/S, Denmark
1.000000
 0.03
Fudan University Shanghai Cancer Center (FUSCC), China
1.000000
 0.03
Asan Medical Center (AMC), South Korea
1.000000
 0.03
Azienda Socio Sanitaria Territoriale (ASST) degli Spedali Civili di Brescia, Italy
1.000000
 0.03
Chaim Sheba Medical Center at Tel HaShomer, Israel
1.000000
 0.03
University Medical Center Groningen (UMCG), RUG, Netherlands
1.000000
 0.03
Fiona Stanley Hospital (FSH), Australia
1.000000
 0.03
Aidport Clinical Trials Hospital, Poland
1.000000
 0.03
D'Or Institute for Research and Education (IDOR), Brazil
1.000000
 0.03
Fundaleu, Argentina
1.000000
 0.03
ABJ Oncology, South Africa
1.000000
 0.03
Cancer Institute Hospital, JFCR, Japan
1.000000
 0.03
Laiko General Hospital of Athens, UOA, Greece
1.000000
 0.03
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)
1.000000
 0.03
Sun Yat-sen University (SYSU), China
1.000000
 0.03
Hospital Universitario 12 de Octubre, Spain
1.000000
 0.03
Paris Cité University, France
0.500000
 0.02
Hôpital Saint-Louis, France
0.500000
 0.02
Paracelsus Medical University (PMU), Austria
0.333333
 0.01
Peter MacCallum Cancer Centre (Peter Mac), Australia
0.333333
 0.01
Royal Melbourne Hospital (RMH), Australia
0.333333
 0.01
The University of Melbourne (UniMelb), Australia
0.333333
 0.01
Cancer Cluster Salzburg (CCS), Austria
0.333333
 0.01
Salzburg Cancer Research Institute (SCRI), Austria
0.333333
 0.01
Interested in Cardiovascular Medicine and Haematology?